Numerous age-related conditions (atherosclerosis, chronic kidney disease, obesity and diabetes, cancer and cognitive impairment) are also associated with elevated GDF-15, making it a clinically relevant biomarker. Here, GDF15 is linked to obesity due to melanocortin 4 receptor deficiency.